Personal tools

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

You are here: Home / Biomarkers / EPB41L3



This biomarker is also known as:
  • Q9Y2J2,
  • 4.1B,
  • differentially expressed in adenocarcinoma of the lung protein 1,
  • band 4.1-like protein 3,
  • DAL-1,
  • erythrocyte membrane protein band 4.1-like 3,
  • KIAA0987,
  • DAL1,
  • Differentially expressed in adenocarcinoma of the lung protein 1,


EPB41L3 protein is a critical growth regulator in the pathogenesis of meningiomas. There are three isoforms of this protein, produced by alternative splicing.


QA State: Curated
Type: Protein
Short Name:
HGNC Name: EPB41L3


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


EPB41L3 has been identified as a functional suppressor of epithelial ovarian cancers.

Performance Comment

EPB41L3 was one of 50 tumor vasculature-associated genes with transmembrane or secreted protein products identified through expression profiling of ovarian cancer vascular cells. These 50 tumor vascular markers (TVMs) also had low or no expression in normal tissues. EPB41L3 was not in the group of 13 selected for further validation.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


Mutation Statistics

Gene Name: EPB41L3
UniProt Accession #: Q9Y2J2
Mutated Sites Count: 247
Associated Pubmed ID Count 23
CancerDO Count 25
Affected Protein Function Sites Count: 4

View in BioMuta